Objective: To evaluate the effectiveness for the construction of the "mosquito-free village" in Jinzishan Village, Fuling District, Chongqing Municipality, so as to provide references for improving mosquito control practices in hilly and mountainous rural areas. Methods: The "mosquito-free village" initiative in Fuling District was launched in April 2023. Mosquito density monitoring was conducted annually from April to October. Larval mosquito density was monitored using the path method and scoop-catch method, and adult mosquito density was monitored using human-baited landing catch. One hundred and fifty-two villagers were randomly conducted before the "mosquito-free village" construction (April 2023) and one hundred and sixty-seven villagers were randomly conducted after the construction (November 2024). Knowledge awareness rate and correct behavioral practices regarding mosquito control among villagers were assessed. The satisfaction among villagers were evaluated in November 2024. The effectiveness of the initiative was evaluated based on mosquito density data, health education outcomes from 2023 to 2024, and satisfaction. Results: The average larval mosquitoes path index in Jinshanzi Village decreased from 1.50 spots/km in 2023 to 0.07 spots/km in 2024 (P<0.05). The average sampling spoon index of larval mosquitoes decreased from 3.43% in 2023 to 0 in 2024. The average landing rate index of adult mosquitoes decreased from 3.90 mosquitoes/(person·time) in 2023 to 0.38 mosquitoes/(person·time) in 2024 (P<0.05). The awareness rate of mosquito control knowledge and the formation rate of correct behaviors among villagers increased from 59.87% and 57.24% in 2023 to 92.22% and 90.42% in 2024, respectively (both P<0.05). In 2024, the satisfaction of villagers was 92.81%. Conclusion The mosquito density, health education effectiveness, and satisfaction of villagers in Jinzishan Village have all met the evaluation criteria for a "mosquito-free village", providing a replicable model for promotion in hilly and mountainous rural areas.

Objective To observe the inhibited effect of gastrodin on chemotherapy-induced neuropathic pain and its mechanism.Methods Fifty SD rats,chosen according to the threshold of pain,were randomly divided into 5 groups(n=10):control group,model group,and gastrodin treatment groups (30 mg/kg,60 mg/kg and 120 mg/kg).Vincristine (125 μg/kg,i.p.) was administered on alternate days to establish chemotherapy-induced neuropathic pain models in the model group and gastrodin treatment groups,and then,on the 9th d of modeling rats in the gastrodin treatment groups were treated with different doses of gastrodin,while those in the control group and model group were given normal saline on the 16th d of modeling.Paw withdrawal mechanical threshold and thermal pain threshold were measured;protein expressions of CX3CR1 and p-p38MAPK were detected by Western blotting,and tumor necrosis factor α (TNF-α) protein expression was detected by ELISA.Results As compared with control group,model group had significantly decreased pain threshold and increased protein expressions of CX3CR1,p-p38MAPK and TNF-α (P＜0.05);as compared with those in the model group,the pain threshold increased and the expressions of CX3CR1,p-p38MAPK and TNF-α decreased in 60 mg/kg and 120 mg/kg gastrodin treatment groups,with significant differences (P＜0.05).Conclusion Gastrodin can relieve the chemotherapy-induced neuropathic pain,probably by inhibiting the expressions of CX3CR1 and p-p38MAPK in the activation passageway of microglial cells in the spinal cord,and then,reducing the expression of TNF-α.